1. Elevated circulating IL-17 level is associated with inflammatory arthritis and disease activity: A meta-analysis
   Xu Zhang et al, 2019, Clinica Chimica Acta CrossRef
2. Complementary medicine for axial spondyloarthritis: is there any scientific evidence?
   Abhijeet Danve et al, 2018, Current Opinion in Rheumatology CrossRef
3. Integrating network pharmacology and experimental verification to explore the mechanism of Tripterygium wilfordii in ankylosing spondylitis
   Yuening Chen et al, 2023, Medicine CrossRef
4. Infusion of umbilical cord mesenchymal stem cells alleviates symptoms of ankylosing spondylitis
   Ai Li et al, 2017, Experimental and Therapeutic Medicine CrossRef
5. Immunological and oxidative stress biomarkers in Ankylosing Spondylitis patients with or without metabolic syndrome
   Alireza Pishgahi et al, 2020, Cytokine CrossRef
6. The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double‐blind, placebo‐controlled clinical trial
   Majid Ahmadi et al, 2020, Journal of Cellular Biochemistry CrossRef
7. Changes and clinical significance of CD8+CD122+ T cells in the peripheral blood of patients with ankylosing spondylitis
   Renfang Han et al, 2018, Clinical Rheumatology CrossRef
8. Tripterygium glycoside ameliorates neuroinflammation in a mouse model of Aβ25-35-induced Alzheimer’s disease by inhibiting the phosphorylation of IκBα and p38
   Liang Tang et al, 2021, Bioengineered CrossRef
9. Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms
   Hui Ying Xu et al, 2015, PLOS ONE CrossRef
10. Treg-promoted New Bone Formation Through Suppressing Th17 by Secreting Interleukin-10 in Ankylosing Spondylitis
    Fan Xu et al, 2019, Spine CrossRef
11. Targets of Tripterygium glycosides in systemic lupus erythematosus treatment: A network-pharmacology study
    Lu Xiao et al, 2022, Lupus CrossRef
12. Protective Effect and Possible Mechanisms of Tripterygium Glycosides in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
    Zhou Lin et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
13. Tripterygium glycoside improves regulatory T cells and attenuates acute organ dysfunction in septic mice
    Xiaoming Zhang et al, 2021, European Journal of Inflammation CrossRef
14. The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis
    Na-Lin Lai et al, 2019, Journal of Immunology Research CrossRef
15. Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis
    Ming Li et al, 2020, BioMed Research International CrossRef
16. Efficacy of tripterygium glycosides tablet in treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials
    Hong Li et al, 2015, Clinical Rheumatology CrossRef
17. Research Progress on Molecular Mechanism of Moxibustion in the Treatment of Ankylosing Spondylitis
    Min Yan et al, 2022, Chinese medicine and natural products CrossRef
18. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice
    Dan Luo et al, 2019, Frontiers of Medicine CrossRef
19. Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis
    Hong-Ki Min et al, 2019, Journal of Translational Medicine CrossRef
20. Efficacy and Safety of Curcumin and Curcuma longa Extract in the Treatment of Arthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trial
    Liuting Zeng et al, 2022, Frontiers in Immunology CrossRef
21. Imbalance of Peripheral Lymphocyte Subsets in Patients With Ankylosing Spondylitis: A Meta-Analysis
    Dong Liu et al, 2021, Frontiers in Immunology CrossRef
22. Identification of the chemical components and metabolites of tripterygium glycoside tablets in mice by HPLC-Q/TOF MS
    Dan Zhang et al, 2019, Journal of Chromatography B CrossRef